XML 39 R26.htm IDEA: XBRL DOCUMENT v3.25.1

INVESTMENT IN RELATED PARTY INVESTMENT FUND (Tables)

3 Months Ended

Mar. 31, 2025

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Financial Information of Investment

The summarized financial statements of Solasglas are presented below.

Summarized Statements of Financial Condition of Solasglas Investments, LP

						March 31, 2025						December 31, 2024
Assets
Investments, at fair value						$	526,047					$	504,828
Derivative contracts, at fair value						35,843						8,925
Due from brokers						264,229						188,296
Cash and cash equivalents						27,375						40,354
Interest and dividends receivable						294						1,536
Total assets						853,788						743,939
Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value						(287,314)						(234,977)
Derivative contracts, at fair value						(3,498)						(4,452)
Capital withdrawals payable						—						(4,000)
Due to brokers						(1,429)						—
Interest and dividends payable						(1,468)						(3,218)
Accrued expenses and other liabilities						(404)						(180)
Total liabilities						(294,113)						(246,827)
Partners' capital						$	559,675					$	497,112
GLRE’s share of Partners' capital						$	435,341					$	387,144

Summarized Statements of Operations of Solasglas Investments, LP

						Three months ended March 31
						2025						2024
Investment income
Dividend income (net of withholding taxes)						$	1,490					$	831
Interest income						3,627						4,352
Total Investment income						5,117						5,183
Expenses
Management fee						(1,730)						(1,323)
Interest						(1,701)						(1,334)
Dividends						(761)						(704)
Research and operating						(485)						(324)
Total expenses						(4,677)						(3,685)
Net investment income						440						1,498
Realized and change in unrealized gains (losses)
Net realized gain (loss)						19,105						42,945
Net change in unrealized appreciation (depreciation)						27,018						(16,245)
Net gain on investment transactions						46,123						26,700
Net increase in Partners' capital (1)						$	46,563					$	28,198
GLRE’s share of the increase in Partners' capital						$	32,197					$	18,248

(1) The net increase in Partners’ capital is net of management fees and performance allocation presented below:

						Three months ended March 31
						2025						2024
Management fees						$	1,730					$	1,323
Performance allocation						3,578						2,028
Total						$	5,308					$	3,351

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

+ Details

Name:	us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration